Time New York: Thu 20 Sep 11:04 am  |  Save 15% on H&R Block Online

  
caticonslite_bm_alt

Tilray (TLRY) Looks Good: Stock Adds 8.5% in Session

Zacks

Tilray, Inc. TLRY was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading within a volatile range of $24.25–$89.86 in the past one-month time frame, showed a sharp increase yesterday.

The company has not seen any estimate revisions in the past month, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Tilray currently has a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical – Drugs industry is BioSpecifics Technologies Corp BSTC, which currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is TLRY going up? Or down? Predict to see what others think: Up or Down

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Zacks Investment Research
<-- You can share this post with your network,
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.